INTESTINE Vol.21 No.4(7)


特集名 腸内細菌をめぐって
題名 生活習慣病と腸内細菌
発刊年月 2017年 07月
著者 入江 潤一郎 慶應義塾大学医学部腎臓内分泌代謝内科
著者 伊藤 裕 慶應義塾大学医学部腎臓内分泌代謝内科
【 要旨 】 食事の偏り,不規則な摂食と睡眠不足などの生活習慣の乱れは,腸内細菌の多様性を減じdysbiosisの原因となり,慢性炎症と腸管ホルモン応答異常を宿主に惹起し,肥満症や2型糖尿病の誘因となる.規則正しい多彩な食事は腸内細菌の恒常性を維持して生活習慣病を予防し,また腸内細菌を標的としたプロバイオティクスや腸管に作用する薬物が,腸内細菌を介した生活習慣病の新たな治療戦略として期待されている.
Theme Impacts of intestinal microbiota
Title Intestinal microbiota in obesity and type 2 diabetes
Author Junichiro Irie Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University
Author Hiroshi Itoh Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University
[ Summary ] Irregular lifestyle habits such as insufficient sleep and an unbalanced diet induce a reduction of the number of bacterial genes (bacterial richness), leading to "dysbiosis," systemic chronic inflammation, and alteration of the intestinal hormone secretion. These changes result in obesity and type 2 diabetes. Regular eating habits maintain the homeostasis of intestinal microbiota and prevent the development of lifestyle-related diseases. Novel therapeutics targeting intestinal microbiota, such as probiotics and medication for gastrointestinal tract has been investigated and expected for lifestyle-related diseases.
戻る